AF
QTTB icon

Advisornet Financial’s Q32 Bio QTTB Stock Holding History

Advisornet Financial’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13 Hold
2
– – ﹤0.01% 2249
2025
Q4 		$7 Hold
2
– – ﹤0.01% 2230
2025
Q3 		$4 Hold
2
– – ﹤0.01% 2232
2025
Q2 		$3 Hold
2
– – ﹤0.01% 2226
2025
Q1 		$3 Hold
2
– – ﹤0.01% 2166
2024
Q4 		$7 Sell
2
-11
-85% -$347 ﹤0.01% 1963
2024
Q3 		$580 Hold
13
– – ﹤0.01% 2013
2024
Q2 		$233 Sell
13
-32
-71% -$766 ﹤0.01% 2019
2024
Q1 		$767 Buy
+45
New +$620 ﹤0.01% 1829

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Advisornet Financial's QTTB Position: Q1 2026 in Review

Advisornet Financial held its Q32 Bio (QTTB) position steady in Q1 2026 at 2 shares worth $13. The position accounts for ﹤0.01% of the portfolio, ranked #2249.

Advisornet Financial first reported a position in QTTB in Q1 2024 and has held it in 9 quarters since. The position peaked at $767 in Q1 2024. 54 funds tracked by Wall St. Rank hold QTTB as of Q1 2026.

  • Advisornet Financial held 2 shares of Q32 Bio worth $13 as of Q1 2026.
  • Advisornet Financial left its Q32 Bio share count unchanged in Q1 2026.
  • Q32 Bio made up ﹤0.01% of Advisornet Financial's portfolio in Q1 2026, its #2249 holding.
  • Advisornet Financial first reported a position in Q32 Bio in Q1 2024 and has held it in 9 quarters since.
  • Advisornet Financial's Q32 Bio position peaked at $767 in Q1 2024.
  • 54 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2026.

Based on Advisornet Financial's 13F filing for Q1 2026, filed 17 Apr 2026.